{"id":"https://openalex.org/W587736953","doi":null,"title":"Long-term effects of fenofibrate on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes","display_name":"Long-term effects of fenofibrate on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes","publication_year":2009,"publication_date":"2009-10-09","ids":{"openalex":"https://openalex.org/W587736953","mag":"587736953"},"language":"en","primary_location":{"id":"pmh:oai:helda.helsinki.fi:10138/22880","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10138/22880","pdf_url":null,"source":{"id":"https://openalex.org/S4210213322","display_name":"Ty\u00f6v\u00e4entutkimus Vuosikirja","issn_l":"0784-1272","issn":["0784-1272","1459-7780"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"doctoralThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10138/22880","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077754008","display_name":"Anne Hiukka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Anne Hiukka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5077754008"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.48899999260902405,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/diabetic-dyslipidemia","display_name":"diabetic dyslipidemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/lipoprotein-subclasses","display_name":"lipoprotein subclasses","score":0.8100000023841858},{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.953000009059906},{"id":"https://openalex.org/keywords/atherogenic-lipoproteins","display_name":"atherogenic lipoproteins","score":0.7900000214576721},{"id":"https://openalex.org/keywords/hdl-subfractions","display_name":"HDL subfractions","score":0.7900000214576721},{"id":"https://openalex.org/keywords/homocysteine","display_name":"homocysteine","score":0.8569999933242798},{"id":"https://openalex.org/keywords/cystatin-c","display_name":"cystatin C","score":0.8339999914169312},{"id":"https://openalex.org/keywords/carotid-intima-media-thickness","display_name":"carotid intima-media thickness","score":0.8899999856948853},{"id":"https://openalex.org/keywords/augmentation-index","display_name":"augmentation index","score":0.8899999856948853},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.843999981880188},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.8579999804496765},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.8866523504257202},{"id":"https://openalex.org/C2778848681","wikidata":"https://www.wikidata.org/wiki/Q6725716","display_name":"Macrovascular disease","level":4,"score":0.825474739074707},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6909029483795166},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5779562592506409},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5131257176399231},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.4896853268146515},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4636017084121704},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43455082178115845},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.23482537269592285},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:helda.helsinki.fi:10138/22880","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10138/22880","pdf_url":null,"source":{"id":"https://openalex.org/S4210213322","display_name":"Ty\u00f6v\u00e4entutkimus Vuosikirja","issn_l":"0784-1272","issn":["0784-1272","1459-7780"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"doctoralThesis"},{"id":"mag:587736953","doi":null,"is_oa":false,"landing_page_url":"https://helda.helsinki.fi/handle/10138/22880","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:helda.helsinki.fi:10138/22880","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10138/22880","pdf_url":null,"source":{"id":"https://openalex.org/S4210213322","display_name":"Ty\u00f6v\u00e4entutkimus Vuosikirja","issn_l":"0784-1272","issn":["0784-1272","1459-7780"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"doctoralThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049360498","https://openalex.org/W2276359858","https://openalex.org/W2086524291","https://openalex.org/W7160222976","https://openalex.org/W2034600674","https://openalex.org/W2124439283","https://openalex.org/W3193575681","https://openalex.org/W1556045720","https://openalex.org/W2008695819","https://openalex.org/W2412456033"],"abstract_inverted_index":{"Background":[0],"and":[1,16,28,41,46,60,63,97,115,162,224,251,272,311,355],"aims.":[2],"Diabetic":[3],"dyslipidemia":[4],"is":[5],"a":[6,22,138,185],"highly":[7],"atherogenic":[8,323],"triad":[9],"of":[10,43,58,68,84,110,180,190,198,204,212,236,241,248,296,304,346,361,369],"increased":[11,150,209,221,289],"triglycerides,":[12,220],"decreased":[13,175,269],"HDL":[14,226,237,249,391],"cholesterol,":[15],"small":[17,186],"dense":[18],"LDL.":[19],"Fibrates":[20],"have":[21,30],"beneficial":[23],"effect":[24,278,342,352],"on":[25,86,279,343,353],"diabetic":[26,104,160,177,199,213,314],"dyslipidemia,":[27],"they":[29],"reduced":[31,39,219],"cardiovascular":[32],"events":[33],"in":[34,73,118,151,157,168,176,188,234,308,334,359,382],"randomized":[35,128],"trials.":[36],"Fenofibrate":[37,218,268,339,349,373],"has":[38],"albuminuria":[40,280,354],"markers":[42,345,360],"low-grade":[44],"inflammation":[45],"endothelial":[47,266],"dysfunction.":[48],"The":[49,125],"present":[50],"studies":[51],"were":[52,106,127,206,243,326],"undertaken":[53],"to":[54,64,70,80,129,154,192,377,389],"characterize":[55],"the":[56,66,82,111,122,166,301,356,366,370],"alterations":[57],"VLDL":[59,172,297],"LDL":[61,69,181,191,214,222,317],"subclasses":[62,227],"investigate":[65],"binding":[67,189,211],"arterial":[71,193],"wall":[72,194],"type":[74,102,158,312,335],"2":[75,103,159,313,336],"diabetes.":[76],"Further":[77],"purpose":[78],"was":[79,145,174,281,288,300],"elucidate":[81],"effects":[83],"fenofibrate":[85,130,254,257,291],"several":[87],"lipoprotein":[88],"subclasses,":[89],"augmentation":[90],"index":[91],"(AIx),":[92],"carotid":[93],"intima-media":[94],"thickness":[95],"(IMT),":[96],"renal":[98,362],"function.":[99,267],"Subjects.":[100],"239":[101],"subjects":[105,310],"recruited":[107],"among":[108],"participants":[109],"FIELD":[112],"(Fenofibrate":[113],"Intervention":[114],"Event":[116],"Lowering":[117],"Diabetes)":[119],"study":[120],"at":[121],"Helsinki":[123],"centre.":[124],"patients":[126,161],"(200mg/d)":[131],"or":[132,265,381],"placebo":[133],"for":[134,208],"5":[135],"years.":[136],"Additionally,":[137],"healthy":[139],"control":[140,163,309],"group":[141],"(N":[142],"=":[143],"93)":[144],"recruited.":[146],"Results.":[147],"VLDL1":[148],"triglycerides":[149,156,299],"similar":[152],"proportion":[153],"total":[155,169],"subjects.":[164],"Despite":[165],"increase":[167,187,247,390],"apoCIII":[170,173,183,320,331],"levels,":[171],"patients.":[178,315,371],"Enrichment":[179],"with":[182,215,231,245,283,318,385],"induced":[184],"proteoglycan.":[195],"Intrinsic":[196],"characteristics":[197],"LDL,":[200],"rather":[201],"than":[202],"levels":[203,235,240],"apoCIII,":[205],"responsible":[207],"proteoglycan":[210],"high":[216,319],"apoCIII.":[217],"size,":[223],"shifted":[225],"towards":[228],"smaller":[229],"particles":[230],"no":[232,341,351],"change":[233],"cholesterol.":[238],"High":[239],"homocysteine":[242],"associated":[244],"lower":[246],"cholesterol":[250],"apoA-I":[252],"during":[253,290],"treatment.":[255,292],"Long-term":[256],"treatment":[258],"did":[259],"not":[260,388],"improve":[261],"IMT,":[262],"AIx,":[263],"inflammation,":[264],"creatinine":[270],"clearance":[271],"estimated":[273],"glomerular":[274],"filtration":[275],"rate.":[276],"No":[277],"seen":[282],"fenofibrate.":[284],"Instead,":[285],"Cystatin":[286],"C":[287],"Conclusions.":[293],"1)":[294],"Elevation":[295],"1":[298],"major":[302],"determinant":[303],"plasma":[305],"triglyceride":[306],"concentration":[307],"2)":[316],"showed":[321],"multiple":[322],"properties,":[324],"that":[325],"only":[327],"partially":[328],"mediated":[329],"by":[330],"per":[332],"se":[333],"diabetes":[337],"3)":[338],"demonstrated":[340],"surrogate":[344],"atherosclerosis.":[347],"4)":[348],"had":[350],"observed":[357],"decrease":[358],"function":[363],"could":[364],"complicate":[365],"clinical":[367],"surveillance":[368],"5)":[372],"can":[374],"be":[375],"used":[376],"treat":[378],"severe":[379],"hypertriglyceridemia":[380],"combination":[383],"therapy":[384],"statins,":[386],"but":[387],"levels.":[392]},"counts_by_year":[],"updated_date":"2026-08-08T01:25:22.217667","created_date":"2016-06-24T00:00:00"}